AHA Before Health Subcommittee Committee on Energy & Commerce Re: Examining the Drug Supply Chain

AHA statement before the Health Subcommittee on Energy & Commerce regarding examing the drug supply chain.

Key Resources

Related Resources

Advancing Health Podcast
How Legal Advocacy Is Shaping the Future of Health Care
Public
Guides/Reports
More Drug Company Oversight Needed to Maintain Compliance with 340B Program Rules
Public
Issue Landing Page
The 340B Drug Pricing Program
Public
Letter/Comment
AHA Urges HHS to Reject the Effort by Several Large Drug Companies to Undermine the 340B Drug Pricing Program
Public
Action Alert
ACT NOW: Urge Your Members of Congress to Protect Medicaid and Other Crucial Programs
Member
Guides/Reports
Costs of Caring
Public